Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 38
- Next page
Title | Authors | Year Sort descending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Vishnu P, Duncan J, Connell N, Cooper N, Lim W, Rodeghiero F, Tomiyama Y, Grace RF, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Health care providers | Benchmarking and standard setting |
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K | 2021 | J Thromb Haemost | View Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Researchers | Clinical research |
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, Kum E, Qasim A, Zeraatkar D, Izcovich A, Mangala S, Ge L, Han MA, Agoritsas T, Arnold D, Ávila C, Chu DK, Couban R, Cusano E, Darzi AJ, Devji T, Foroutan F, Ghadimi M, Khamis A, Lamontagne F, Loeb M, Miroshnychenko A, Motaghi S, Murthy S, Mustafa RA, Rada G, Rochwerg B, Switzer C, Vandvik PO, Vernooij RW, Wang Y, Yao L, Guyatt GH, Brignardello-Petersen R | 2021 | BMJ | View Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Researchers | Clinical research |
Rapport de surveillance 2020 | O'Brien S | 2021 | Blood.ca website | View Rapport de surveillance 2020 | Health care providers | Benchmarking and standard setting |
Anaphylactic transfusion reactions and IgA deficiency | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Anaphylactic transfusion reactions and IgA deficiency | Health care providers | Benchmarking and standard setting |
Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Hadjesfandiari N, Khorshidfar M, Devine DV | 2021 | Int J Mol Sci | View Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Blood operators | New or improved product or process |
Diagnostic approach to the adult with unexplained thrombocytopenia | Arnold D, Cuker A | 2021 | UptoDate | View Diagnostic approach to the adult with unexplained thrombocytopenia | Health care providers | Benchmarking and standard setting |
Proposal of the Definition for COVID-19-Associated Coagulopathy | Iba T, Warkentin TE, Thachil J, Levi M, Levy JH | 2021 | J Clin Med | View Proposal of the Definition for COVID-19-Associated Coagulopathy | Health care providers | Clinical research |
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Ting J, Yeung K, Paes B, Chan AKC, Petropoulos JA, Banfield L, Bhatt MD | 2021 | Blood Coagul Fibrinolysis | View How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Health care providers | Clinical research |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Saeed S, O’Brien SF, Abe K, Yi Q-L, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews SJ | 2021 | PLoS One | View Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Health care providers | Benchmarking and standard setting |
Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Day D, Lin Y | 2021 | Ontario Regional Blood Coordinating Network September 2021 Newsletter | View Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Health care providers | Benchmarking and standard setting |
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Marceau D, Huang A, Carr H, Lin Y, Lall R, Graham C, Arsenault C, Sales V, Sidhu D, Semret M, Hamm C, Arhanchiague E, Solh Z, Srour N, Soliman K, Yee C, Laroche V, Nahirniak S, Greenaway C, Pai M, Côté A, Tsang JLY, Cserti-Gazdewich C, Talbot D, Poulin S, Guimaraes R, Rushton-Marovac M, Langlois A, Ning S, Shih A, Boileau M, Singh H, Ledingham D, Ponnampalam A, Yan M, Prokopchuk-Gauk O, Poirier A, Girouard G, Pavenski K, Drouin O, Harris D, Durand M, Rimmer E, Ovakim D, Ménard F, Cuccarolo G, Carruthers J, Lucier K, Arsenault V, Auclair M-C, Avram M, Brassard M, Cerro S, Martinez V, Morin J, Saint-Jacques M, Veillette M, Armali C, Kron A, Modi D, Duncan J, Justumus P, John MS, St-Onge G, Hadzi-Tosev M, Dion P-M, McGillivary L, de Moulliac AV, Nyman SA, Perilli S, Van Vliet PJ, Lane S, Pavenski K, Pereira R, Sirotich E, Abelson J, Greene S, Khandelwal A, Thakar S, Longo S, Anand SP, Benlarbi M, Bourassa C, Boutin M, Descôteaux-Dinelle J, Gendron-Lepage G, Goyette G, Laumaea A, Medjahed H, Prévost J, Richard J, Kaufmann D, Brunet-Ratnasingham E, Chaumont N, Drebot M, Robinson A, Mendoza E, Dimitrova K, Manguiat K, Phillipson C, Chan M, Evans D, Lin J, Boyer L, Cloutier M, Drouin M, Ducas É, Dussault N, Fournier M-J, Landy P, Nolin M-È, Perreault J, Tremblay T, Nazy I, Xie F, Liu D, Wong M, Silverio G, Walkus K, Barton M, Haveman K, Mueller D, Scott A, Moher M, Wood G, Roarty T, Auld F, Carney G, Thomson V, Onell R, Walley K, Donohoe K, Brunk C, Hernandez G, Jacobucci T, Lazosky L, Mann P, Raval G, Zampieri LA, Sekhon M, Wright A, James N, Chang G, Chen R, Deol K, Gantioqui J, Larsen E, Ramdin N, Roche M, Rosinski K, Sham L, Storms M, Gillrie M, Mahe E, Suryanarayan D, Ugarte-Torres A, Robinson T, Gibbs M, Hewsgirard J, Holmes M, McCarthy J, Ody M, Doucette K, Sligl W, Sonpar A, Robertson K, Narayan J, Ravindran L, Stewart B, Zapernick L, Lee S, Sy E, Wong A, Gryzb K, Craddock S, Fuchs D, Myrah D, Sunny S, Harding SR, Kogilwaimath S, Hodgson N, Johnson D, Meier S, Thomson K, Heendeniya A, Houston B, Kenyan Y, Lother S, Olafson K, Rush B, Wuerz T, Solvason D, Albensi L, Alias S, Choi N, Curtis L, Hutmacher M, Kashani H, Lane D, Marten N, Pronyk-Ward T, Rigaux L, Silva R, Tays Q, Naidu R, Mathews J, Mai M, Miceli V, Molson L, Radhakrishnan G, Schaefer L, Haddad M, Landry S, Chernish R, Kruisselbrink R, Liu T, Jeromin J, Siddiqui A, Girolametto C, Krokoszynski K, Main C, Fox-Robichaud A, Rochwerg B, Kruja E, Ellingham D, Sampat D, Tang N, Leto D, Karunakaran M, Ricciuto D, Fusco K, Ghate T, Robinson H, Ball I, Shalhoub S, Slessarev M, Silverman M, Nano E, Bentall T, Campbell E, Kinney J, Parvathy S, Fera E, Delfa AL, Nadarajah J, Solow H, Mendoza E, Engel K, Monaco D, Kononow L, Suntharalingam S, Fralick M, Munshi L, Saeed S, Hajjaj O, Hsu E, Ali K, Duan E, Farjou G, Jenson L, Salib M, Patterson L, Anant S, Ding J, Jomy J, Das P, Geagea A, the Concor-Study Group | 2021 | Nat Med | View Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Health care providers | Clinical research |
Concentré de recherche: Traitement périopératoire des patients atteints de thrombocytopénie immunitaire : comparaison de l’eltrombopag et des immunoglobulines intraveineuses | Arnold DM | 2021 | Blood.ca website | Health care providers | Clinical research | |
High sub-zero organ preservation: A paradigm of nature-inspired strategies | William N, Acker JP | 2021 | Cryobiology | View High sub-zero organ preservation: A paradigm of nature-inspired strategies | Researchers | Basic research |
Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Paredes C, Chi SI, Flint A, Weedmark K, McDonald C, Bearne J, Ramirez-Arcos S, Pagotto F, Baltrus DA | 2021 | Microbiol Resour Announc | View Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Researchers | Benchmarking and standard setting |
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O’Brien SF, the Surveillance Risk Assessment Policy tVS-gotI, Transfusion Transmitted Infectious Diseases Working Party | 2021 | Vox Sang | View An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Blood operators | Benchmarking and standard setting |
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Huang CT, Hsu SY, Wang CH, Tseng WJ, Yang CY, Ng CJ, Warkentin TE, Cheng MH | 2021 | Thromb Res | View Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL | 2021 | Transfusion | View The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Blood operators | Benchmarking and standard setting |
Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Shopsowitz KE, Lim C, Shih AW, Fishbane N, Berry BR, Bigham M, Petraszko T, Trudeau J, Wyatt M, Yan MTS, Morrison D | 2022 | Vox Sang | View Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Blood operators | Benchmarking and standard setting |
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Drews SJ, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Yi Q-L, O’Brien SF, Mostafa HH | 2022 | Microbiol Spectr | View SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Researchers | Clinical research |
Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W, Ning S | 2022 | Guide de la pratique transfusionnelle | View Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies | Holmberg JA, Henry SM, Burnouf T, Devine D, Marschner S, Boothby TC, Burger SR, Chou ST, Custer B, Blumberg N, Siegel DL, Spitalnik SL | 2022 | Transfusion | View National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies | Researchers | Benchmarking and standard setting |
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia | Li N, Mahamad S, Parpia S, Iorio A, Foroutan F, Heddle NM, Hsia CC, Sholzberg M, Rimmer E, Shivakumar S, Sun HL, Refaei M, Hamm C, Arnold DM | 2022 | J Thromb Haemost | View Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia | Researchers | New or improved product or process |
Surveillance report | O'Brien SF | 2022 | Blood.ca website | View Surveillance report | Blood operators | Benchmarking and standard setting |
Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex | Sask KN, Thong B, Goodarzynejad N, Berry LR, Chan AKC | 2022 | Biointerphases | View Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex | Researchers | Basic research |
GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach | Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, Traversy G, Akl EA, Mayer M, Schünemann HJ, Guyatt GH | 2022 | J Clin Epidemiol | View GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach | Researchers | Clinical research |
Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Thompson T, Callum J | 2022 | Ontario Regional Blood Coordinating Network February 2022 Newsletter | View Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Health care providers | Clinical research |
Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study | Razatos A, Acker JP, de Korte D, Bégué S, Noorman F, Doyle B, Zia M, Min K, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study | Researchers | New or improved product or process |
International Forum on the Management of Major Haemorrhage: Responses | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Responses | Health care providers | Benchmarking and standard setting |
International survey of strategies to mitigate transfusion-transmitted Trypanosoma cruzi in non-endemic countries, 2016–2018 | Crowder LA, Wendel S, Bloch EM, O'Brien SF, Delage G, Sauleda S, Leiby DA, for the WP-TTID Subgroup on Parasites | 2022 | Vox Sang | View International survey of strategies to mitigate transfusion-transmitted Trypanosoma cruzi in non-endemic countries, 2016–2018 | Researchers | Benchmarking and standard setting |
(NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus | Almizraq RJ, Frias Boligan K, Loriamini M, McKerlie C, Branch DR | 2022 | Front Immunol | View (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus | Researchers | Basic research |
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Giles JB, Steiner HE, Rollin J, Shaffer CM, Momozawa Y, Mushiroda T, Inai C, Selleng K, Thiele T, Pouplard C, Heddle NM, Kubo M, Miller EC, Martinez KL, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM, Karnes JH | 2022 | Blood Adv | View Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
Circular of information for the use of human blood components: Whole Blood | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Whole Blood | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Holloway K, Simms N, Hayeems RZ, Miller FA | 2022 | Hastings Cent Rep | View The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Regulators | Ethical, legal and social implications research |
Complement contributions to COVID-19 | Conway EM, Pryzdial ELG | 2022 | Curr Opin Hematol | View Complement contributions to COVID-19 | Researchers | Basic research |
Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Hahn B, Quee F, Prinsze FJ, Gregoire Y, O'Brien SF, Germain M, van de Laar T, Zaaijer HL, van den Hurk K | 2022 | Transfusion | View Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Blood operators | MSM research |
Evolving policies for donors with diabetes: The Canadian experience | Miller O, Caffrey N, O'Brien SF, Goldman M | 2022 | Vox Sang | View Evolving policies for donors with diabetes: The Canadian experience | Researchers | New or improved product or process |
Chapter 17. Hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 17. Hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Assessing the quality of stored red blood cells using handheld Spatially Offset Raman spectroscopy with multisource correlation analysis | Vardaki MZ, Georg Schulze H, Serrano K, Blades MW, Devine DV, F. B. Turner R | 2022 | Spectrochim Acta A Mol Biomol | View Assessing the quality of stored red blood cells using handheld Spatially Offset Raman spectroscopy with multisource correlation analysis | Researchers | New or improved product or process |
Acute thrombocytopenia suggesting thrombotic microangiopathy | Venier LM, Patriquin CJ, Warkentin TE | 2022 | Am J Hematol | View Acute thrombocytopenia suggesting thrombotic microangiopathy | Health care providers | Clinical research |
An uncertain association between influenza season, recent influenza vaccination campaigns, and unconfirmed repeat reactive syphilis serology assay results in Canadian blood donors | Drews SJ, Bodnar M, Gill B, Carson D, Hawes G, Yi QL, Tran V, Zhou HY, Bigham M, O'Brien SF | 2022 | Transfusion | View An uncertain association between influenza season, recent influenza vaccination campaigns, and unconfirmed repeat reactive syphilis serology assay results in Canadian blood donors | Researchers | Benchmarking and standard setting |
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021 | Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Robbins NF, Orjuela G, Jenkins C, Conrod V, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021 | Researchers | Benchmarking and standard setting |
Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Dryden OH | 2022 | Harriet’s Legacies: Race, Historical Memory, and Futures in Canada | View Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Researchers | MSM research |
Automated closed volume reduction process for apheresis stem cell grafts: From development to clinical implementation | Howell A, Letcher B, Murphy K, Elmoazzen H, Petraszko T, Acker JP, Pineault N, Holovati JL | 2022 | Transfusion | View Automated closed volume reduction process for apheresis stem cell grafts: From development to clinical implementation | Researchers | New or improved product or process |
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Li N, Zeller MP, Shih AW, Heddle NM, St. John M, Bégin P, Callum J, Arnold DM, Akbari-Moghaddam M, Down DG, Jamula E, Devine DV, Tinmouth A | 2022 | Transfusion | View A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Researchers | Clinical research |
Rapport de surveillance | O'Brien SF | 2022 | Blood.ca website | View Rapport de surveillance | Blood operators | Benchmarking and standard setting |
Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Schmidt M, Ramirez-Arcos S, Stiller L, McDonald C, ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | 2022 | Vox Sang | View Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Researchers | Benchmarking and standard setting |
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Zhang X, Chen F, Chen X, Cheng Y, Fang M, Feng J, Fu H, Gao H, Han Y, He A, Hou M, Hu Y, Huang R, Huang W, Jing Z, Kong P, Liang A, Liang M, Liu D, Liu J, Liu L, Liu X, Ma L, Mei H, Ni H, Niu T, Peng J, Qiao J, Ren J, Song Y, Tang LV, Tong T, Wang S, Wang X, Wang Z, Wei H, Wu D, Wu G, Xu C, Xu X, Xu Y, Yang L, Yang R, Yang T, Yin C, Yu L, Zhang G, Zhang L, Zhang L, Zhang X, Zhao W, Zhao Y, Zhou D, Zhou H, Zhou Z, Zhu T, Wang J, Huang X | 2022 | Chin Med J (Engl) | View 2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Health care providers | Clinical research |